/Investor DB

Kicker Ventures — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Swing TherapeuticsinJun 2022Acquired

Digital therapeutics developer behind Stanza, an FDA-authorized smartphone behavioral therapy for fibromyalgia symptoms.

BiotechHealthtechSan Francisco, US

Michael Rosenbluth(Executive Officer, Director)

BoardAndrew Firlik(Director)inZack Lynch(Director)inCorey McCann(Director)

PartnerMasashi Kiyomine· solo GP

Co-investorsAlumni VenturesAME Cloud VenturesAsahi Kasei Corporate VenturesGaingelsJAZZ Venture PartnersMana Ventures+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.